COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing cardiometabolic care, announced today that it was Certified™ by Great Place to Work® for the fourth year in a row. This prestigious award recognizes companies with exceptional workplace cultures based solely on employee feedback. An impressive 94 percent of employees said Welldoc is a great place to … [Read more…]
Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in presentations and in a live case transmission HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will be featured in several presentations … [Read more…]
Alliance will give insurers more flexible and precise risk assessment for life insurance, enabling greater targeting and personalized offers ZURICH & BOZEMAN, Mont.–(BUSINESS WIRE)–Global analytics software leader FICO and dacadoo, a global leader in customer engagement via a digital wellness tracking platform and health risk quantification product offering, have partnered to enhance the way insurance … [Read more…]
Innate to regain its rights on CD123 targeting ANKET® SAR443579 (SAR’579) /IPH6101 currently in development for AML Potential investment of up to €15M by Sanofi in Innate Pharma through a capital increase, subject to market conditions Sanofi to continue development of BCMA targeting ANKET® program in autoimmune indications Innate still eligible for more than €1 … [Read more…]
BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its first quarter 2025 results after the market closes on Tuesday, May 6, 2025. A conference call will be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended March 31, 2025 after the market close on … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Excipients – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Pharmaceutical Excipients was valued at USD 10.2 Billion in 2024 and is projected to reach USD 13.3 Billion by 2030, growing at a CAGR of 4.5% from 2024 to 2030. This comprehensive report provides an … [Read more…]
HOUSTON & NEW YORK–(BUSINESS WIRE)–Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, and Weill Cornell Medicine have entered into a strategic collaboration to develop AI for personalized assessments of patient disease prognosis and evolution. Initially, the collaboration will focus on leukemia, leveraging the Weill Cornell Leukemia Program’s vast biorepository of bone marrow … [Read more…]
Agreement enables Bayer to leverage ConcertAI Translational360™ and AI SaaS Solutions to leverage insights derived from AI and machine learning CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI’s Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology. The agreement … [Read more…]
GALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced two significant milestones in its mission to improve stroke care: 1) the completion of patient enrollment in its U.S. pivotal IDE clinical trial, MARRS (Millipede Aspiration for Revascularization in Stroke Study), and 2) the appointment of seasoned … [Read more…]
